Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

about

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

Item

http://www.wikidata.org/entity/Q48112019

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prevalence of Ankylosing Spond ...... ted with TNF-alpha inhibitors.

@en

Prevalence of Ankylosing Spondylitis Disease Activity Score

@nl

type

Item

label

Prevalence of Ankylosing Spond ...... ted with TNF-alpha inhibitors.

@en

Prevalence of Ankylosing Spondylitis Disease Activity Score

@nl

prefLabel

Prevalence of Ankylosing Spond ...... ted with TNF-alpha inhibitors.

@en

Prevalence of Ankylosing Spondylitis Disease Activity Score

@nl

P1476

Prevalence of Ankylosing Spond ...... ated with TNF-alpha inhibitors

@en

P2093

Martina Biggioggero

http://www.w3.org/2001/XMLSchema#string

Monica Todoerti

http://www.w3.org/2001/XMLSchema#string

Veronica Codullo

http://www.w3.org/2001/XMLSchema#string

P2860

Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?

Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohort.

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.

ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.

How to measure disease activity in axial spondyloarthritis?

How to define remission in ankylosing spondylitis?

P304

542-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14397595.2017.1367076

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ennio Giulio Favalli

Andrea Becciolini

Sara Monti

Carlomaurizio Montecucco

Roberto Caporali

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28880727

http://www.w3.org/2001/XMLSchema#string

P921

TNF